Eric Green
Showing 1–3 of 3 transcripts.
- Milken Institute1h 3m
How the Past and Present Will Shape Russia's Future | Global Conference 2025
Julia Ioffe, Eric Green, Pavel Khodorkovsky, Maria Snegovaya, Daniel Treisman, Leonid Volkov
Panelists projecting a five to twenty-year timeline for regime change emphasize that Russia's highly personalistic structure and emerging oligarch class will likely delay democratization until after Vladimir Putin's natural exit. Concurrently, the Russian economy has demonstrated surprising resilience through sanctions evasion and deepening ties with China, fostering a militarized society poised for prolonged attrition in Ukraine despite long-term stagnation risks. The discussion concludes that the post-Putin transition will likely result in a turbulent, non-democratic power struggle rather than an immediate liberal shift, while offering comparative lessons on the necessity of active civil society to safeguard democratic norms elsewhere.
- Milken Institute1h 26m
The California-Israel Innovation Project (audio only)
Jerry Brown, Benjamin Netanyahu, Glenn, Tom Soto, David Nahai, Shlomo Labet, Yariv Cohen, Nathan, Martha Amram, Jagdeep Basher, Lee Wallach, Eric Green, Sean Landris, Gil Galanos, Yair
California and Israel formalized a historic government-to-government partnership targeting water security, climate resilience, and biomedical innovation through strategic collaboration between state agencies and anchor entities like IDE and Netafim. Key outcomes include a planned Los Angeles task force to deploy Israeli leak detection technology within the LADWP, the proposal of a $20 billion joint super bio fund to address capital gaps in deep-tech sectors, and a shift toward utilizing California physicians for clinical training in Israel. Future initiatives prioritize establishing shared data platforms for health and agriculture while aligning regulatory frameworks to facilitate long-term infrastructure investment and global market scaling.
- Milken Institute58 min
The Role of Universities in Accelerating Bioscience Research
David Baltimore, Joel Burdick, James Economou, Michael Quick, Owen Witte, Stephen Mayo, Steve Mayo, Nick, Francis Collins, Remy, Joe Boistak, Charles, Eric Green, Ray Deshaies
A consortium of leading academic figures, including Nobel Laureate David Baltimore and experts from Caltech, UCLA, and USC, convened to evaluate the intersection of biological engineering and clinical translation in the face of funding constraints. The panel detailed successful strategies for "engineered immunity" projects, such as converting muscle cells into antibody producers and conducting early-stage human trials within university settings, while highlighting the critical need for interdisciplinary programs that bridge the gap between engineering PhDs and MDs. Despite progress, participants identified a persistent "valley of death" in early-stage financing and urged a cultural shift toward professional management and team-based funding mechanisms to sustain innovation.